David completed his BSc. in Molecular Biophysics and Biochemistry at Yale University, where he developed a keen interest in RNA biology while working in the lab of Dr. Joan Steitz. He delved further into this field under the supervision of Dr. David Bartel at MIT, where he used high-throughput sequencing methods to examine vertebrate alternative polyadenylation and influenza cap-snatching. After receiving his PhD, David worked in the biotech sector on developing robust bioinformatic methods for analysing single-cell immunosequencing data at AbVitro and subsequently Juno Therapeutics. At the Kirby Institute, he is applying genomic and single-cell techniques to address questions at the intersection of immunology and virology in the VISP program.